Information about Adjuvans
My details
*
*
*

Adjuvans (SRL)

BE 0668.392.653

Adriaansensweg 29, 8900 Ieper

Company information

Status
Active

Enterprise number

BE0668.392.653

VAT liability
Yes
Established
23-12-2016
Last balance sheet year
2024
Company size
Small 0 FTE
Principal activity
Business and other management consultancy activities
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

Try for free Discover more

7-day free trial, no credit card required.

Financial data from Adjuvans

2024 2023 2022 2021
Profit/Loss € 73,914 -8 % € 80,237 -9 % € 88,613 -69 % € 286,461
Equity € 973,148 8 % € 900,900 10 % € 822,329 8 % € 758,716
Gross margin € 103,136 -6 % € 110,218 -10 % € 122,062 0 % € 122,358

Publications from Adjuvans

Date Publication
22-12-2023 Articles of Association (Translation, Coordination, Other Modifications, …) - Modification Legal Form - Goal - Resignations, Appointments (FR)
09-10-2023 Registered Office (FR)
28-12-2016 Rubric Constitution (New Juridical Person, Opening Branch, etc...) (FR)

Frequently asked questions

What is the VAT number of Adjuvans?
The VAT number of Adjuvans is BE 0668.392.653.
Wat is the PEPPOL ID of Adjuvans?
The PEPPOL ID of Adjuvans is 0208:0668392653. Log in or start a free trial to see the full overview.
When was Adjuvans founded?
Adjuvans was founded on 23-12-2016.
What is the address of Adjuvans?
The current registered office of Adjuvans is located at Adriaansensweg 29, 8900 Ieper.
When was the last time Adjuvans filed their annual financial statements?
The most recent financial statements of Adjuvans were filed on 30-08-2025.
How many employees does Adjuvans have?
There are currently no employees working at Adjuvans or no workforce information is available.
What is the annual turnover of Adjuvans?
At the time of its most recent financial statements, Adjuvans did not publish any turnover figures. Adjuvans reported a gross margin of €103,135.52.

Sources